Outside primary metabolic indications, these mechanisms are also of interest for cardiometabolic risk reduction (such as waist circumference, triglycerides, and blood pressure) and for appetite control during lifestyle-based weight loss plans
hdl:11104/0259798
[1] It has not received marketing authorisation from the MHRA or the EMA, as confirmed by the MHRA Medicines Database, and is therefore not legally available as a licensed medicine in the UK
The connection between GHK-Cu, copper delivery to copper-dependent enzymes, and downstream effects on collagen and matrix biology has substantial supporting research across multiple decades
10.1002/cne.23846 13 BrazeauP.ValeW.BurgusR.LingN.ButcherM.RivierJ.et al
The primary sources for this report include: Recalls (Enforcement Reports Database)+ The Food and Drug Administration (FDA) categorizes product recalls in its Enforcement Report database based on the level of health risk, labeling them as Class I, II, III, or "not yet classified." While the database includes drugs, food, cosmetics, medical devices, biologics, tobacco, and veterinary products, this report only covers selected drug recalls
